Endothelial protein C receptor
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 18–210 | Fragment:Extracellular domain | Vitamin-K dependent protein C × 1 (P04070) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PTY PHOSPHATIDYLETHANOLAMINE × 1 CA CALCIUM ION × 7 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;peg 400, potassium chloride, magnesium chloride, calcium chloride, hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K | Resolution 1.60 Å R-free 0.222 |
| 2 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain B; UniProt 18–210 | Fragment:Extracellular domain | Vitamin-K dependent protein C × 1 (P04070) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PTY PHOSPHATIDYLETHANOLAMINE × 1 CA CALCIUM ION × 7 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;peg 400, potassium chloride, magnesium chloride, calcium chloride, hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K | Resolution 1.60 Å R-free 0.222 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1LQV | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1L8J Crystal Structure of the Endothelial Protein C Receptor and Bound Phospholipid Molecule Deposited 2002-03-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
Fragment:Extracellular domain (residues 18-210)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;Sodium Formate, TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
|
Resolution 2.00 Å R-free 0.211 |
| 3JTC Importance of Mg2+ in the Ca2+-Dependent Folding of the gamma-Carboxyglutamic Acid Domains of Vitamin K-Dependent clotting and anticlotting Proteins Deposited 2009-09-11 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
18–210(193 aa)
Fragment:extracellular domain (UNP residues 18-210)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PTY PHOSPHATIDYLETHANOLAMINE × 1 MG MAGNESIUM ION × 2 CA CALCIUM ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;PEG 400, potassium chloride, magnesium chloride, calcium chloride, HEPES, PH 7.0, VAPOR DIFFUSION
|
Resolution 1.60 Å R-free 0.226 |
| 3JTC Importance of Mg2+ in the Ca2+-Dependent Folding of the gamma-Carboxyglutamic Acid Domains of Vitamin K-Dependent clotting and anticlotting Proteins Deposited 2009-09-11 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
18–210(193 aa)
Fragment:extracellular domain (UNP residues 18-210)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PTY PHOSPHATIDYLETHANOLAMINE × 1 MG MAGNESIUM ION × 2 CA CALCIUM ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;PEG 400, potassium chloride, magnesium chloride, calcium chloride, HEPES, PH 7.0, VAPOR DIFFUSION
|
Resolution 1.60 Å R-free 0.226 |
| 4V3D The CIDRa domain from HB3var03 PfEMP1 bound to endothelial protein C receptor Deposited 2014-10-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
25–194(170 aa)
Fragment:EXTRACELLULAR DOMAIN, UNP RESIDUES 468-718
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.2 M NANO3, 0.1 M BTP PH 8.5, 20% PEG 3350
|
Resolution 2.65 Å R-free 0.255 |
| 4V3D The CIDRa domain from HB3var03 PfEMP1 bound to endothelial protein C receptor Deposited 2014-10-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
25–194(170 aa)
Fragment:EXTRACELLULAR DOMAIN, UNP RESIDUES 468-718
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.2 M NANO3, 0.1 M BTP PH 8.5, 20% PEG 3350
|
Resolution 2.65 Å R-free 0.255 |
| 4V3E The CIDRa domain from IT4var07 PfEMP1 bound to endothelial protein C receptor Deposited 2014-10-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
25–195(171 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;0.2 M NANO3, 0.1 M BTP PH 7.5, 20% PEG 3350
|
Resolution 2.90 Å R-free 0.276 |
| 6SNY Synthetic mimic of an EPCR-binding PfEMP1 bound to EPCR Deposited 2019-08-27 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;2M sodium citrate, 0.1M HEPES pH 7
|
Resolution 3.11 Å R-free 0.256 |
| 6SNY Synthetic mimic of an EPCR-binding PfEMP1 bound to EPCR Deposited 2019-08-27 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;2M sodium citrate, 0.1M HEPES pH 7
|
Resolution 3.11 Å R-free 0.256 |
| 7OKS X-ray structure of soluble EPCR in P212121 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;2.8 M sodium acetate pH 8.0, 0.1 M Tris pH 7.0
|
Resolution 1.95 Å R-free 0.239 |
| 7OKS X-ray structure of soluble EPCR in P212121 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;2.8 M sodium acetate pH 8.0, 0.1 M Tris pH 7.0
|
Resolution 1.95 Å R-free 0.239 |
| 7OKS X-ray structure of soluble EPCR in P212121 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;2.8 M sodium acetate pH 8.0, 0.1 M Tris pH 7.0
|
Resolution 1.95 Å R-free 0.239 |
| 7OKS X-ray structure of soluble EPCR in P212121 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;2.8 M sodium acetate pH 8.0, 0.1 M Tris pH 7.0
|
Resolution 1.95 Å R-free 0.239 |
| 7OKT X-ray structure of soluble EPCR in C2221 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 EDO 1,2-ETHANEDIOL × 1 PTY PHOSPHATIDYLETHANOLAMINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;2.8 M Sodium acetate pH 7.0
|
Resolution 1.95 Å R-free 0.257 |
| 7OKT X-ray structure of soluble EPCR in C2221 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
18–210(193 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 PTY PHOSPHATIDYLETHANOLAMINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;2.8 M Sodium acetate pH 7.0
|
Resolution 1.95 Å R-free 0.257 |
| 7OKU X-ray structure of soluble EPCR in P3121 space group Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 EDO 1,2-ETHANEDIOL × 2 PTY PHOSPHATIDYLETHANOLAMINE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;2.0 M Sodium formate, 0.1 M Sodium acetate pH 4.6
|
Resolution 1.95 Å R-free 0.235 |
| 7OKV Crystal structure of soluble EPCR after exposure to the nonionic surfactant Polysorbate 20 Deposited 2021-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 R16 HEXADECANE × 1 HEX HEXANE × 1 D10 DECANE × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;3.5 M Sodium formate, 0.1 M Sodium acetate pH 4.6
|
Resolution 1.85 Å R-free 0.234 |
| 7Q5D Structure of EPCR in a non-canonical conformation Deposited 2021-11-03 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
18–210(193 aa)
|
Not recorded | CYS CYSTEINE × 1 PTY PHOSPHATIDYLETHANOLAMINE × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.1 M sodium-potassium tartrate, 20% w/v PEG 3350
|
Resolution 1.80 Å R-free 0.195 |
| 8C44 HB3VAR03 apo headstructure (PfEMP1 A) complexed with EPCR Deposited 2022-12-31 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
26–193(168 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å |
| 9TJX Structure of factor VII Gla domain bound to EPCR Deposited 2025-12-08 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
18–210(193 aa)
|
Not recorded | SO4 SULFATE ION × 2 PTY PHOSPHATIDYLETHANOLAMINE × 1 CA CALCIUM ION × 5 MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M Ammonium sulfate, 0.1 M Tris PH 8.5, 12 % w/v PEG 8000
|
Resolution 3.00 Å R-free 0.295 |
| 9TJX Structure of factor VII Gla domain bound to EPCR Deposited 2025-12-08 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
18–210(193 aa)
|
Not recorded | SO4 SULFATE ION × 2 PTY PHOSPHATIDYLETHANOLAMINE × 1 CA CALCIUM ION × 5 MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M Ammonium sulfate, 0.1 M Tris PH 8.5, 12 % w/v PEG 8000
|
Resolution 3.00 Å R-free 0.295 |
| 9TJX Structure of factor VII Gla domain bound to EPCR Deposited 2025-12-08 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
18–210(193 aa)
|
Not recorded | PTY PHOSPHATIDYLETHANOLAMINE × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 CA CALCIUM ION × 5 MG MAGNESIUM ION × 2 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M Ammonium sulfate, 0.1 M Tris PH 8.5, 12 % w/v PEG 8000
|
Resolution 3.00 Å R-free 0.295 |
| 9TJX Structure of factor VII Gla domain bound to EPCR Deposited 2025-12-08 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
18–210(193 aa)
|
Not recorded | SO4 SULFATE ION × 1 PTY PHOSPHATIDYLETHANOLAMINE × 1 CA CALCIUM ION × 5 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M Ammonium sulfate, 0.1 M Tris PH 8.5, 12 % w/v PEG 8000
|
Resolution 3.00 Å R-free 0.295 |
12 other PDB entries and 22 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | EPCR_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–193; UniProt 18–210 Author chain B; PDBConstruct 1–193; UniProt 18–210 |